MarginsXMarginsX
Home › Markets › Health Care › STIM

Neuronetics Inc. (STIM)

STIM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.25
-10.07% on the day
Market cap
$120.6M
Micro cap
Revenue · 2025
$149.2M
+99.2% on 2024
Net income · 2025
-$39.0M
-26.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1227636/000110465926029004/0001104659-26-029004-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSTIM on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2018
SEC CIK0001227636
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$149.2M
Net income-$39.0M
Operating income-$31.4M
Net margin-26.1%
Operating margin-21.1%
Revenue growth+99.2%
Cash$28.1M
Total assets$141.6M
P/E (computed)Net income was not positive
P/S (computed)0.8×

Warning signs

Cash runway
31.9 months
$22.1M cash at September 30, 2026
Share count, 1 year
+13.5%
2025-10-29 to 2026-10-28 · +168.6% over 3 years
Going-concern doubt
Yes
10-Q filed November 4, 2026
Insider net buying, 12 months
$4.5M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Therefore, substantial doubt exists about the Company's ability to continue as a going concern."
10-Q 2026-11-04
Cash and burn$22.1M cash; operating cash flow -$2.1M a quarter.Report 2026-09-30
Shares outstanding77,728,311 (2026-10-28); 68,485,922 a year earlier; 28,933,132 three years earlier.Cover page 2026-10-28
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-11-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $4.8M, sold $282K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$42.0M-$1.7M$1.2M$22.1M$61.8M$159.8M10-Q 2026-11-04
Q2 2026
2026-06-30
$41.6M-$3.4M-$1.0M$19.2M$61.5M$155.1M10-Q 2026-08-11
Q1 2026
2026-03-31
$34.5M-$10.8M-$9.4M$13.2M$61.3M$151.6M10-Q 2026-05-05
Q4 2025
2025-12-31
$41.8M-$7.2M$882K$28.1M$65.8M$149.2M10-K 2026-03-17
Q3 2025
2025-09-30
$37.3M-$9.0M-$785K$28.0M$65.7M$129.9M10-Q 2026-11-04
Q2 2025
2025-06-30
$38.1M-$10.1M-$3.5M$11.0M$55.5M$111.1M10-Q 2026-08-11
Q1 2025
2025-03-31
$32.0M-$12.7M-$17.0M$20.2M$55.3M$89.4M10-Q 2026-05-05
Q4 2024
2024-12-31
$22.5M-$12.7M-$8.6M$18.5M$55.2M$74.9M10-K 2026-03-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-11-12
Latest annual report10-K2026-03-17
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K/A2026-11-12
Latest proxyDEFA14A2026-04-09

Source: SEC EDGAR submissions feed, 729 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-35.3%
1 month-30.2%
3 months-54.1%
Year to date+0.7%
1 year-31.9%
From 52-week high-57.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
LUNGPulmonx Corporation$2.80-2.10%$121.9M
PYPDPolyPid Ltd.$6.15-1.76%$124.9M
APYXApyx Medical Corporation$2.65-5.69%$111.6M
SKYASkyAI Inc.$2.11-9.05%$107.3M
SKINSkinHealth Systems Inc.$15.05-7.73%$98.5M
KRMDKORU Medical Systems Inc. Common Stock (DE)$3.69-0.27%$160.1M
NYXHNyxoah SA$0.8937-0.64%$89.4M
ANIKAnika Therapeutics Inc.$12.92-3.58%$173.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier